Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Classificação em ações #38911
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Preço da ação
$0.1645
Valor de mercado
$681.26K
Variação (1 dia)
-3.69%
Variação (1 ano)
-95.30%
País
US
Negociar Valion Bio, Inc. (VBIO)

Categoria

Healthcare
Histórico de preços das ações de Valion Bio, Inc. (VBIO)
Preço de fecho mais alto: $0.24 em 2026-08-01

Preço de fecho mais baixo: $7.60K em 2021-11-01
Histórico de preços das ações da Valion Bio, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -21.26%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.40 29.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $842.41 29.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $726.49 6.37%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.46 11.09%
BE